Agenda

Monday Tuesday Wednesday Thursday

Monday, November 29, 2021
8:30 am	Welcome and Introductions Daniel Culver, DO, Co-Activity Director Manuel Ribeiro Neto, MD, Co-Activity Director Session Chairs: Wim Wuyts, MD, PhD and Brian Southern, MD
8:35 am	Progressive Fibrosis: Lumping, Splitting, Both or Neither Athol Wells, MD
8:55 am	Innate Immune Mechanisms in Fibrotic Lung Disease Bethany Moore, PhD
9:15 am	Role of Lymphocytes in Pulmonary Fibrosis Catherine Bonham, MD
9:35 am	New Findings in the Genetics of Fibrosis in African Americans Courtney Gray Montgomery, PhD
9:55 am	Metabolic Mediators of Fibrosis Victor Thannickal, MD
10:15 am	Exhibit Break
10:40 am	Intersection between Fibrosis and Inflammation Elizabeth Redente, PhD
11:00 am	A Systems Biology Approach to Understanding Granuloma Formation in Tuberculosis Denise Kirschner, PhD
11:20 am	Predicting Outcomes in Fibrotic ILD Justin Oldham, MD
11:40 am	Panel Discussion - All Session Faculty
12:00 pm	Lunch Break / Networking Lounge Session Chairs: Antje Prasse, MD, and Laura Koth, MD
12:45 pm	Innate Immune Mechanisms in Sarcoidosis Thomas Weichhart, MD
1:05 pm	Identifying an Etiologic Trigger for Sarcoidosis Andrew Fontenot, MD
1:25 pm	Pro/Con: Funding Agencies Should Concentrate on Funding for a Specific Etiology Pro - Wonder Drake, MD Con - Elliott Crouser, MD
1:55 pm	Panel Discussion - All Session Faculty
2:15 pm	Adjourn

Tuesday, November 30, 2021
8:25 am	Welcome and Introductions Daniel Culver, DO, Co-Activity Director Manuel Ribeiro Neto, MD, Co-Activity Director Session Chairs: Kristin Highland, MD, and Martin Kolb, MD, PhD
8:30 am	Pulmonary Vasculature in ILD: Bystander or Culprit Bruno Crestani, MD
8:45 am	Angiogenesis in Fibrosis Maximillian Ackermann, MD
9:00 am	Vascular-parenchymal Relationships in Fibrotic Lung Disease Toyoshi Yanagihara, MD
9:15 am	Therapies for Pulmonary Hypertension in ILD Steven Nathan, MD
9:30 am	Panel Discussion - All session faculty
9:50 am	Exhibit Break Session Chairs: Robert Baughman, MD, and Hilario Nunes, MD, PhD
10:10 am	Epidemiology and Natural Course of SAPH Oksana Shlobin, MD
10:25 am	Screening and Diagnosis of SAPH Marloes Huitema, MD
10:40 am	Treatment Principles for SAPH Laurent Savale, MD
10:55 am	Riociguat for SAPH: Results of Double Blind Placebo Controlled Trial Rohit Gupta, MD
11:10 am	Panel Discussion – All session faculty
11:30 am	Break Session Chairs: Karen Patterson, MD, and Remy Mostard, MD, PhD
11:50 am	Chest CT as a Basis of Integrative Biomarkers in Sarcoidosis Lisa Maier, MD, MSPH
12:05 pm	CT Phenotypes in Sarcoidosis; Results of a Delphi Project Nishanth Sivarasan, MBBS
12:20 pm	Artificial Intelligence and Deep Learning Approaches for Imaging ILD Simon Walsh, MD
12:35 pm	Deep Learning for Quantification Stephen Humphries, PhD
12:50 pm	Clinical Context for Quantitative Imaging: Will It Help Manage My Patient? Jan Grutters, MD, PhD
1:05 pm	Panel Discussion - All Session Faculty
1:25 pm	Adjourn to Networking Lounge

Wednesday, December 1, 2021
8:25 am	Welcome and Introductions Daniel Culver, DO, Co-Activity Director Manuel Ribeiro Neto, MD, Co-Activity Director Session Chairs: Marjolein Drent, MD, PhD, and Marlies Wijsenbeek, MD
8:30 am	ERS Treatment Guidelines Overview Dominique Valeyre, MD
8:45 am	Are the ERS Guidelines Helpful? Marc Judson, MD
9:00 am	Pro/Con: Most Patients with Progressive Fibrotic Sarcoidosis Should Receive Antifibrotics Pro – Athol Wells, MD Con - Katerina Antoniou, MD, PhD
9:30 am	Current Treatment Landscape Discussion - All Session Faculty
9:50 am	Networking Break Session Chairs: Francesco Bonella, MD, PhD, and Alicia Gerke, MD, MBA
10:15 am	Trials: Abasarc Björn Frye, MD
10:30 am	Trials: Pirfenidone for fibrotic pulmonary sarcoidosis Robert Baughman, MD
10:45 am	Trials: aTyr Ennis James, MD
11:00 am	Thoughts on Clinical Trial Design in Sarcoidosis Daniel Culver, DO
11:15 am	Panel Discussion - All Session Faculty
11:30 am	Exhibit Break Session Chairs: Paolo Spagnolo, MD, PhD, and Nabeel Hamzeh, MD
11:50 am	Pro/Con: PET Scan Should be Adopted as a Routine Tool for Sarcoidosis Management and Clinical Trials Pro – Robert Baughman, MD Con – Marc Judson, MD
12:20 pm	Genes and Environment are Key Determinants of Sarcoidosis Natalia Rivera, MD
12:35 pm	Socioeconomic Determinants and Disparities in Sarcoidosis Michelle Sharp, MD, MHS
12:50 pm	Panel Discussion - All Session Faculty
1:15 pm	Adjourn

Thursday, December 2, 2021
8:25 am	Welcome and Introductions Daniel Culver, DO, Co-Activity Director Manuel Ribeiro Neto, MD, Co-Activity Director Session Chairs: Marcel Veltkamp, MD, PhD, and Manuel Ribeiro Neto, MD
8:30 am	Update on Arrhythmias in CS Jordana Kron, MD
8:50 am	Risk Stratification for Sudden Cardiac Death; Known Knowns and Known Unknowns Kengo Kusano, MD
9:05 am	Immunosuppressive Therapy for CS: Who and How to Treat and for How Long? Manuel Ribeiro Neto, MD
9:25 am	Panel Discussion - All Session Faculty
9:50 am	Pro/Con: All Patients with CS Should Receive an ICD Pro - Sana M. Al-Khatib, MD Con - Annelies Bakker, MD
10:15 am	Exhibit Break Session Chairs: David Birnie, MD, and Christine Jellis, MD, PhD
10:35 am	Screening for Cardiac Sarcoidosis: In Whom, When, and How? Vasilis Kouranos, MD, PhD
10:50 am	MRI Imaging of Cardiac Sarcoidosis: Indications, Techniques, Pitfalls and Future Directions Chetan Shenoy, MBBS
11:05 am	FDG-PET Imaging of CS: Indications, Techniques, Pitfalls, Recent Guidelines, and Future Directions Ron Blankstein, MD
11:20 am	Panel Discussion - All Session Faculty
11:45 am	Break / Networking Lounge Session Chairs: Ziad Taimeh, MD, and Divya Patel, DO
12:10 pm	Pro/Con: Is Isolated Cardiac Sarcoidosis an Important Diagnosis? Pro: Leslie Cooper, Jr., MD Con: David Birnie, MD
12:35 pm	My Nightmare CS Case: Difficult Case Management for Discussion Daniel Culver, DO David Birnie, MD Ron Blankstein, MD Vasilis Kouranos, MD, PhD Rakesh Sharma, MBBS, PhD Manuel Ribeiro Neto, MD, Moderator
1:15 pm	Panel Discussion - All Daily Faculty
1:45 pm	Closing Remarks and Adjourn

Agenda

Monday, November 29, 2021

Tuesday, November 30, 2021

Wednesday, December 1, 2021

Thursday, December 2, 2021